FDA gives CryoLife conditional approval for PerClot device

06/20/2013 | American City Business Journals

The FDA has granted CryoLife conditional investigational device exemption approval for its PerClot system. The company said the device, which consists of absorbable polysaccharide granules, is designed for use as an ancillary hemostatic tool when conventional methods to control bleeding during surgery are impractical or ineffective.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park